Request for Covid-19 Impact Assessment of this Report
The United States Pet Veterinary Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pet Veterinary Drug market, reaching US$ million by the year 2028. As for the Europe Pet Veterinary Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pet Veterinary Drug players cover Boehringer Ingelheim International GmbH, Zoetis Animal Healthcare, Bayer AG, and Merck Animal Health, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Veterinary Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Veterinary Hospitals
Veterinary Clinics
Drug Stores
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Boehringer Ingelheim International GmbH
Zoetis Animal Healthcare
Bayer AG
Merck Animal Health
Elanco Animal Health Inc.
Virbac Group
Ceva
Dechra Pharmaceuticals Plc
Vetoquinol
Orion Corporation
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pet Veterinary Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pet Veterinary Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pet Veterinary Drug by Country/Region, 2017, 2022 & 2028
2.2 Pet Veterinary Drug Segment by Type
2.2.1 Anti-Infectives
2.2.2 Anti-Inflammatory
2.2.3 Parasiticides
2.2.4 Analgesics
2.2.5 Sedatives
2.2.6 Others
2.3 Pet Veterinary Drug Sales by Type
2.3.1 Global Pet Veterinary Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Pet Veterinary Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pet Veterinary Drug Sale Price by Type (2017-2022)
2.4 Pet Veterinary Drug Segment by Application
2.4.1 Veterinary Hospitals
2.4.2 Veterinary Clinics
2.4.3 Drug Stores
2.5 Pet Veterinary Drug Sales by Application
2.5.1 Global Pet Veterinary Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Pet Veterinary Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pet Veterinary Drug Sale Price by Application (2017-2022)
3 Global Pet Veterinary Drug by Company
3.1 Global Pet Veterinary Drug Breakdown Data by Company
3.1.1 Global Pet Veterinary Drug Annual Sales by Company (2020-2022)
3.1.2 Global Pet Veterinary Drug Sales Market Share by Company (2020-2022)
3.2 Global Pet Veterinary Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Pet Veterinary Drug Revenue by Company (2020-2022)
3.2.2 Global Pet Veterinary Drug Revenue Market Share by Company (2020-2022)
3.3 Global Pet Veterinary Drug Sale Price by Company
3.4 Key Manufacturers Pet Veterinary Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Veterinary Drug Product Location Distribution
3.4.2 Players Pet Veterinary Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pet Veterinary Drug by Geographic Region
4.1 World Historic Pet Veterinary Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Pet Veterinary Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pet Veterinary Drug Annual Revenue by Geographic Region
4.2 World Historic Pet Veterinary Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Pet Veterinary Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pet Veterinary Drug Annual Revenue by Country/Region
4.3 Americas Pet Veterinary Drug Sales Growth
4.4 APAC Pet Veterinary Drug Sales Growth
4.5 Europe Pet Veterinary Drug Sales Growth
4.6 Middle East & Africa Pet Veterinary Drug Sales Growth
5 Americas
5.1 Americas Pet Veterinary Drug Sales by Country
5.1.1 Americas Pet Veterinary Drug Sales by Country (2017-2022)
5.1.2 Americas Pet Veterinary Drug Revenue by Country (2017-2022)
5.2 Americas Pet Veterinary Drug Sales by Type
5.3 Americas Pet Veterinary Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Veterinary Drug Sales by Region
6.1.1 APAC Pet Veterinary Drug Sales by Region (2017-2022)
6.1.2 APAC Pet Veterinary Drug Revenue by Region (2017-2022)
6.2 APAC Pet Veterinary Drug Sales by Type
6.3 APAC Pet Veterinary Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pet Veterinary Drug by Country
7.1.1 Europe Pet Veterinary Drug Sales by Country (2017-2022)
7.1.2 Europe Pet Veterinary Drug Revenue by Country (2017-2022)
7.2 Europe Pet Veterinary Drug Sales by Type
7.3 Europe Pet Veterinary Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pet Veterinary Drug by Country
8.1.1 Middle East & Africa Pet Veterinary Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pet Veterinary Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Pet Veterinary Drug Sales by Type
8.3 Middle East & Africa Pet Veterinary Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Veterinary Drug
10.3 Manufacturing Process Analysis of Pet Veterinary Drug
10.4 Industry Chain Structure of Pet Veterinary Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Veterinary Drug Distributors
11.3 Pet Veterinary Drug Customer
12 World Forecast Review for Pet Veterinary Drug by Geographic Region
12.1 Global Pet Veterinary Drug Market Size Forecast by Region
12.1.1 Global Pet Veterinary Drug Forecast by Region (2023-2028)
12.1.2 Global Pet Veterinary Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet Veterinary Drug Forecast by Type
12.7 Global Pet Veterinary Drug Forecast by Application
13 Key Players Analysis
13.1 Boehringer Ingelheim International GmbH
13.1.1 Boehringer Ingelheim International GmbH Company Information
13.1.2 Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Offered
13.1.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Boehringer Ingelheim International GmbH Main Business Overview
13.1.5 Boehringer Ingelheim International GmbH Latest Developments
13.2 Zoetis Animal Healthcare
13.2.1 Zoetis Animal Healthcare Company Information
13.2.2 Zoetis Animal Healthcare Pet Veterinary Drug Product Offered
13.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Zoetis Animal Healthcare Main Business Overview
13.2.5 Zoetis Animal Healthcare Latest Developments
13.3 Bayer AG
13.3.1 Bayer AG Company Information
13.3.2 Bayer AG Pet Veterinary Drug Product Offered
13.3.3 Bayer AG Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bayer AG Main Business Overview
13.3.5 Bayer AG Latest Developments
13.4 Merck Animal Health
13.4.1 Merck Animal Health Company Information
13.4.2 Merck Animal Health Pet Veterinary Drug Product Offered
13.4.3 Merck Animal Health Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Merck Animal Health Main Business Overview
13.4.5 Merck Animal Health Latest Developments
13.5 Elanco Animal Health Inc.
13.5.1 Elanco Animal Health Inc. Company Information
13.5.2 Elanco Animal Health Inc. Pet Veterinary Drug Product Offered
13.5.3 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Elanco Animal Health Inc. Main Business Overview
13.5.5 Elanco Animal Health Inc. Latest Developments
13.6 Virbac Group
13.6.1 Virbac Group Company Information
13.6.2 Virbac Group Pet Veterinary Drug Product Offered
13.6.3 Virbac Group Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Virbac Group Main Business Overview
13.6.5 Virbac Group Latest Developments
13.7 Ceva
13.7.1 Ceva Company Information
13.7.2 Ceva Pet Veterinary Drug Product Offered
13.7.3 Ceva Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Ceva Main Business Overview
13.7.5 Ceva Latest Developments
13.8 Dechra Pharmaceuticals Plc
13.8.1 Dechra Pharmaceuticals Plc Company Information
13.8.2 Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Offered
13.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Dechra Pharmaceuticals Plc Main Business Overview
13.8.5 Dechra Pharmaceuticals Plc Latest Developments
13.9 Vetoquinol
13.9.1 Vetoquinol Company Information
13.9.2 Vetoquinol Pet Veterinary Drug Product Offered
13.9.3 Vetoquinol Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Vetoquinol Main Business Overview
13.9.5 Vetoquinol Latest Developments
13.10 Orion Corporation
13.10.1 Orion Corporation Company Information
13.10.2 Orion Corporation Pet Veterinary Drug Product Offered
13.10.3 Orion Corporation Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Orion Corporation Main Business Overview
13.10.5 Orion Corporation Latest Developments
14 Research Findings and Conclusion
Table 1. Pet Veterinary Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pet Veterinary Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Anti-Infectives
Table 4. Major Players of Anti-Inflammatory
Table 5. Major Players of Parasiticides
Table 6. Major Players of Analgesics
Table 7. Major Players of Sedatives
Table 8. Major Players of Others
Table 9. Global Pet Veterinary Drug Sales by Type (2017-2022) & (K Units)
Table 10. Global Pet Veterinary Drug Sales Market Share by Type (2017-2022)
Table 11. Global Pet Veterinary Drug Revenue by Type (2017-2022) & ($ million)
Table 12. Global Pet Veterinary Drug Revenue Market Share by Type (2017-2022)
Table 13. Global Pet Veterinary Drug Sale Price by Type (2017-2022) & (USD/Unit)
Table 14. Global Pet Veterinary Drug Sales by Application (2017-2022) & (K Units)
Table 15. Global Pet Veterinary Drug Sales Market Share by Application (2017-2022)
Table 16. Global Pet Veterinary Drug Revenue by Application (2017-2022)
Table 17. Global Pet Veterinary Drug Revenue Market Share by Application (2017-2022)
Table 18. Global Pet Veterinary Drug Sale Price by Application (2017-2022) & (USD/Unit)
Table 19. Global Pet Veterinary Drug Sales by Company (2020-2022) & (K Units)
Table 20. Global Pet Veterinary Drug Sales Market Share by Company (2020-2022)
Table 21. Global Pet Veterinary Drug Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Pet Veterinary Drug Revenue Market Share by Company (2020-2022)
Table 23. Global Pet Veterinary Drug Sale Price by Company (2020-2022) & (USD/Unit)
Table 24. Key Manufacturers Pet Veterinary Drug Producing Area Distribution and Sales Area
Table 25. Players Pet Veterinary Drug Products Offered
Table 26. Pet Veterinary Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Pet Veterinary Drug Sales by Geographic Region (2017-2022) & (K Units)
Table 30. Global Pet Veterinary Drug Sales Market Share Geographic Region (2017-2022)
Table 31. Global Pet Veterinary Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Pet Veterinary Drug Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Pet Veterinary Drug Sales by Country/Region (2017-2022) & (K Units)
Table 34. Global Pet Veterinary Drug Sales Market Share by Country/Region (2017-2022)
Table 35. Global Pet Veterinary Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Pet Veterinary Drug Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Pet Veterinary Drug Sales by Country (2017-2022) & (K Units)
Table 38. Americas Pet Veterinary Drug Sales Market Share by Country (2017-2022)
Table 39. Americas Pet Veterinary Drug Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Pet Veterinary Drug Revenue Market Share by Country (2017-2022)
Table 41. Americas Pet Veterinary Drug Sales by Type (2017-2022) & (K Units)
Table 42. Americas Pet Veterinary Drug Sales Market Share by Type (2017-2022)
Table 43. Americas Pet Veterinary Drug Sales by Application (2017-2022) & (K Units)
Table 44. Americas Pet Veterinary Drug Sales Market Share by Application (2017-2022)
Table 45. APAC Pet Veterinary Drug Sales by Region (2017-2022) & (K Units)
Table 46. APAC Pet Veterinary Drug Sales Market Share by Region (2017-2022)
Table 47. APAC Pet Veterinary Drug Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Pet Veterinary Drug Revenue Market Share by Region (2017-2022)
Table 49. APAC Pet Veterinary Drug Sales by Type (2017-2022) & (K Units)
Table 50. APAC Pet Veterinary Drug Sales Market Share by Type (2017-2022)
Table 51. APAC Pet Veterinary Drug Sales by Application (2017-2022) & (K Units)
Table 52. APAC Pet Veterinary Drug Sales Market Share by Application (2017-2022)
Table 53. Europe Pet Veterinary Drug Sales by Country (2017-2022) & (K Units)
Table 54. Europe Pet Veterinary Drug Sales Market Share by Country (2017-2022)
Table 55. Europe Pet Veterinary Drug Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Pet Veterinary Drug Revenue Market Share by Country (2017-2022)
Table 57. Europe Pet Veterinary Drug Sales by Type (2017-2022) & (K Units)
Table 58. Europe Pet Veterinary Drug Sales Market Share by Type (2017-2022)
Table 59. Europe Pet Veterinary Drug Sales by Application (2017-2022) & (K Units)
Table 60. Europe Pet Veterinary Drug Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Pet Veterinary Drug Sales by Country (2017-2022) & (K Units)
Table 62. Middle East & Africa Pet Veterinary Drug Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Pet Veterinary Drug Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Pet Veterinary Drug Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Pet Veterinary Drug Sales by Type (2017-2022) & (K Units)
Table 66. Middle East & Africa Pet Veterinary Drug Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Pet Veterinary Drug Sales by Application (2017-2022) & (K Units)
Table 68. Middle East & Africa Pet Veterinary Drug Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Pet Veterinary Drug
Table 70. Key Market Challenges & Risks of Pet Veterinary Drug
Table 71. Key Industry Trends of Pet Veterinary Drug
Table 72. Pet Veterinary Drug Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Pet Veterinary Drug Distributors List
Table 75. Pet Veterinary Drug Customer List
Table 76. Global Pet Veterinary Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 77. Global Pet Veterinary Drug Sales Market Forecast by Region
Table 78. Global Pet Veterinary Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Pet Veterinary Drug Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Pet Veterinary Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Americas Pet Veterinary Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Pet Veterinary Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 83. APAC Pet Veterinary Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Pet Veterinary Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Europe Pet Veterinary Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Pet Veterinary Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 87. Middle East & Africa Pet Veterinary Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Pet Veterinary Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 89. Global Pet Veterinary Drug Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Pet Veterinary Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Pet Veterinary Drug Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Pet Veterinary Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 93. Global Pet Veterinary Drug Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Pet Veterinary Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Pet Veterinary Drug Revenue Market Share Forecast by Application (2023-2028)
Table 96. Boehringer Ingelheim International GmbH Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Offered
Table 98. Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 99. Boehringer Ingelheim International GmbH Main Business
Table 100. Boehringer Ingelheim International GmbH Latest Developments
Table 101. Zoetis Animal Healthcare Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Zoetis Animal Healthcare Pet Veterinary Drug Product Offered
Table 103. Zoetis Animal Healthcare Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 104. Zoetis Animal Healthcare Main Business
Table 105. Zoetis Animal Healthcare Latest Developments
Table 106. Bayer AG Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Bayer AG Pet Veterinary Drug Product Offered
Table 108. Bayer AG Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 109. Bayer AG Main Business
Table 110. Bayer AG Latest Developments
Table 111. Merck Animal Health Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Merck Animal Health Pet Veterinary Drug Product Offered
Table 113. Merck Animal Health Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 114. Merck Animal Health Main Business
Table 115. Merck Animal Health Latest Developments
Table 116. Elanco Animal Health Inc. Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Elanco Animal Health Inc. Pet Veterinary Drug Product Offered
Table 118. Elanco Animal Health Inc. Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 119. Elanco Animal Health Inc. Main Business
Table 120. Elanco Animal Health Inc. Latest Developments
Table 121. Virbac Group Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Virbac Group Pet Veterinary Drug Product Offered
Table 123. Virbac Group Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 124. Virbac Group Main Business
Table 125. Virbac Group Latest Developments
Table 126. Ceva Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. Ceva Pet Veterinary Drug Product Offered
Table 128. Ceva Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 129. Ceva Main Business
Table 130. Ceva Latest Developments
Table 131. Dechra Pharmaceuticals Plc Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 132. Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Offered
Table 133. Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 134. Dechra Pharmaceuticals Plc Main Business
Table 135. Dechra Pharmaceuticals Plc Latest Developments
Table 136. Vetoquinol Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 137. Vetoquinol Pet Veterinary Drug Product Offered
Table 138. Vetoquinol Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 139. Vetoquinol Main Business
Table 140. Vetoquinol Latest Developments
Table 141. Orion Corporation Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 142. Orion Corporation Pet Veterinary Drug Product Offered
Table 143. Orion Corporation Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 144. Orion Corporation Main Business
Table 145. Orion Corporation Latest Developments
List of Figures
Figure 1. Picture of Pet Veterinary Drug
Figure 2. Pet Veterinary Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Veterinary Drug Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Pet Veterinary Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pet Veterinary Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Anti-Infectives
Figure 10. Product Picture of Anti-Inflammatory
Figure 11. Product Picture of Parasiticides
Figure 12. Product Picture of Analgesics
Figure 13. Product Picture of Sedatives
Figure 14. Product Picture of Others
Figure 15. Global Pet Veterinary Drug Sales Market Share by Type in 2021
Figure 16. Global Pet Veterinary Drug Revenue Market Share by Type (2017-2022)
Figure 17. Pet Veterinary Drug Consumed in Veterinary Hospitals
Figure 18. Global Pet Veterinary Drug Market: Veterinary Hospitals (2017-2022) & (K Units)
Figure 19. Pet Veterinary Drug Consumed in Veterinary Clinics
Figure 20. Global Pet Veterinary Drug Market: Veterinary Clinics (2017-2022) & (K Units)
Figure 21. Pet Veterinary Drug Consumed in Drug Stores
Figure 22. Global Pet Veterinary Drug Market: Drug Stores (2017-2022) & (K Units)
Figure 23. Global Pet Veterinary Drug Sales Market Share by Application (2017-2022)
Figure 24. Global Pet Veterinary Drug Revenue Market Share by Application in 2021
Figure 25. Pet Veterinary Drug Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Pet Veterinary Drug Revenue Market Share by Company in 2021
Figure 27. Global Pet Veterinary Drug Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Pet Veterinary Drug Revenue Market Share by Geographic Region in 2021
Figure 29. Global Pet Veterinary Drug Sales Market Share by Region (2017-2022)
Figure 30. Global Pet Veterinary Drug Revenue Market Share by Country/Region in 2021
Figure 31. Americas Pet Veterinary Drug Sales 2017-2022 (K Units)
Figure 32. Americas Pet Veterinary Drug Revenue 2017-2022 ($ Millions)
Figure 33. APAC Pet Veterinary Drug Sales 2017-2022 (K Units)
Figure 34. APAC Pet Veterinary Drug Revenue 2017-2022 ($ Millions)
Figure 35. Europe Pet Veterinary Drug Sales 2017-2022 (K Units)
Figure 36. Europe Pet Veterinary Drug Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Pet Veterinary Drug Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Pet Veterinary Drug Revenue 2017-2022 ($ Millions)
Figure 39. Americas Pet Veterinary Drug Sales Market Share by Country in 2021
Figure 40. Americas Pet Veterinary Drug Revenue Market Share by Country in 2021
Figure 41. United States Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Pet Veterinary Drug Sales Market Share by Region in 2021
Figure 46. APAC Pet Veterinary Drug Revenue Market Share by Regions in 2021
Figure 47. China Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Pet Veterinary Drug Sales Market Share by Country in 2021
Figure 54. Europe Pet Veterinary Drug Revenue Market Share by Country in 2021
Figure 55. Germany Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Pet Veterinary Drug Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Pet Veterinary Drug Revenue Market Share by Country in 2021
Figure 62. Egypt Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Pet Veterinary Drug in 2021
Figure 68. Manufacturing Process Analysis of Pet Veterinary Drug
Figure 69. Industry Chain Structure of Pet Veterinary Drug
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...